Dengue in the context of "safe blood" and global epidemiology: To screen or not to screen?

Transfusion

Volumn 52, Issue 8, 2012, Pages 1634-1639

  Lanteri, Marion C ^a,b   Busch, Michael P ^a,b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNITY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCREENING TEST; SEROPREVALENCE;

BLOOD BANKS; COMMUNICABLE DISEASES, EMERGING; DENGUE; HUMANS; MASS SCREENING; WORLD HEALTH;

EID: 84864989070     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03747.x     Document Type: Review

References (53)

1. Asnis DS, Conetta R, Waldman G, Teixeira AA,. The West Nile virus encephalitis outbreak in the United States (1999-2000): from Flushing, New York, to beyond its borders. Ann N Y Acad Sci 2001; 951: 161-71.
2. Biggerstaff BJ, Petersen LR,. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002; 42: 1019-26.
3. Petersen LR, Marfin AA, Gubler DJ,. West Nile virus. JAMA 2003; 290: 524-8.
4. US Food and Drug Administration. Guidance for industry: recommendations for the assessment of donor suitability and blood and blood product safety in cases of known or suspected West Nile virus infection. Final guidance. Silver Spring (MD): FDA; 2002.
5. Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH,. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005; 353: 460-7.
6. Biggerstaff BJ, Petersen LR,. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 2003; 43: 1007-17.
7. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY,. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005; 353: 451-9.
8. Petersen LR, Carson PJ, Biggerstaff BJ, Custer B, Borschardt SM, Busch MP,. Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol Infect 2012 May 28. [Epub ahead of print].
9. Alter HJ, Stramer SL, Dodd RY,. Emerging infectious diseases that threaten the blood supply. Semin Hematol 2007; 44: 32-41.
10. Dodd RY,. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003; 349: 1205-6.
11. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY,. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49 Suppl 2: 1S-29S.
12. Simmons CP, Farrar JJ, Nguyen vV, Wills B,. Dengue. N Engl J Med 2012; 366: 1423-32.
13. Lambrechts L, Scott TW, Gubler DJ,. Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis 2010; 4: e646.
14. Mousson L, Dauga C, Garrigues T, Schaffner F, Vazeille M, Failloux AB,. Phylogeography of Aedes (Stegomyia) aegypti (L.) and Aedes (Stegomyia) albopictus (Skuse) (Diptera: Culicidae) based on mitochondrial DNA variations. Genet Res 2005; 86: 1-11.
15. Mackenzie JS, Gubler DJ, Petersen LR,. Emerging Flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004; 10: S98-109.
16. Gubler DJ,. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11: 480-96.
17. Thomas S, Strickman D, Vaughn D,. Dengue epidemiology: virus epidemiology, ecology, and emergence. In:, Chambers T, Monath T, editors. The Flaviviruses: detection, diagnosis and vaccine development. London: Elsevier Academic Press; 2003. p. 235-89.
18. Gubler DJ, Clark GG,. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995; 1: 55-7.
19. Runge-Ranzinger S, Horstick O, Marx M, Kroeger A,. What does dengue disease surveillance contribute to predicting and detecting outbreaks and describing trends? Trop Med Int Health 2008; 13: 1022-41.
20. Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, Dung NM, Hung NT, Hien TT, Farrar JJ,. The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006; 368: 170-3.
21. van de Weg CA, van Gorp EC, Supriatna M, Soemantri A, Osterhaus AD, Martina BE,. Evaluation of the 2009 WHO dengue case classification in an Indonesian pediatric cohort. Am J Trop Med Hyg 2012; 86: 166-70.
22. Moore CG,. Aedes albopictus in the United States: current status and prospects for further spread. J Am Mosq Control Assoc 1999; 15: 221-7.
23. Moore CG, Mitchell CJ,. Aedes albopictus in the United States: ten-year presence and public health implications. Emerg Infect Dis 1997; 3: 329-34.
24. Lee JH, Stahl M, Sawlis S, Suzuki S,. A potential risk assessment of a dengue outbreak in north central Texas, USA. (Part 2 of 2): development of a practical prevention strategy. J Environ Health 2009; 71: 36-9.
25. Lee JH, Stahl M, Sawlis S, Suzuki S,. A potential risk assessment of a dengue outbreak in north central Texas, USA. (Part 1 of 2): abundance and temporal variation of dengue vectors. J Environ Health 2009; 71: 24-9.
26. Graham AS, Pruszynski CA, Hribar LJ, DeMay DJ, Tambasco AN, Hartley AE, Fussell EM, Michael SF, Isern S,. Mosquito-associated dengue virus, Key West, Florida, USA, 2010. Emerg Infect Dis 2011; 17: 2074-5.
27. Radke EG, Gregory CJ, Kintziger KW, Sauber-Schatz EK, Hunsperger EA, Gallagher GR, Barber JM, Biggerstaff BJ, Stanek DR, Tomashek KM, Blackmore CG,. Dengue outbreak in Key West, Florida, USA, 2009. Emerg Infect Dis 2012; 18: 135-7.
28. McCredie J,. Dengue fever epidemic hits northern Australia. BMJ 2009; 338: b967.
29. Diseases of Environmental and Zoonotic Origin Team, European Centre for Disease Prevention and Control. Dengue worldwide: an overview of the current situation and the implications for Europe. Euro Surveill 2007; 12: E070621.1.
30. European Centre for Disease Prevention and Control. Expert consultation on West Nile virus infection. 2011. [cited 2012 Jun 12]. Available from: URL: http://www.ecdc.europa.eu/en/publications/Publications/1106-MER-WNV-Expert- Consultation.pdf
31. Jelinek T,. Trends in the epidemiology of dengue fever and their relevance for importation to Europe. Euro Surveill 2009; 14: pii: 19250.
32. Jelinek T, Muhlberger N, Harms G, Corachan M, Grobusch MP, Knobloch J, Bronner U, Laferl H, Kapaun A, Bisoffi Z, Clerinx J, Puente S, Fry G, Schulze M, Hellgren U, Gjorup I, Chalupa P, Hatz C, Matteelli A, Schmid M, Nielsen LN, da Cunha S, Atouguia J, Myrvang B, Fleischer K,. Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis 2002; 35: 1047-52.
33. Pinazo MJ, Munoz J, Betica L, Maretic T, Zekan S, Avsic-Zupanc T, Sequeira E, Trilla A, Gascon J,. Imported dengue hemorrhagic fever, Europe. Emerg Infect Dis 2008; 14: 1329-30.
34. Reiter P,. Yellow fever and dengue: a threat to Europe? Euro Surveill 2010; 15: 19509.
35. Allicock OM, Lemey P, Tatem AJ, Pybus OG, Bennett SN, Mueller BA, Suchard MA, Foster JE, Rambaut A, Carrington CV,. Phylogeography and population dynamics of dengue viruses in the Americas. Mol Biol Evol 2012.
36. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E,. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 2010; 6: e1000790.
37. Chuang VW, Wong TY, Leung YH, Ma ES, Law YL, Tsang OT, Chan KM, Tsang IH, Que TL, Yung RW, Liu SH,. Review of dengue fever cases in Hong Kong during 1998 to 2005. Hong Kong Med J 2008; 14: 170-7.
38. Tambyah PA, Koay ES, Poon ML, Lin RV, Ong BK,. Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008; 359: 1526-7.
39. Linnen JM, Vinelli E, Sabino EC, Tobler LH, Hyland C, Lee TH, Kolk DP, Broulik AS, Collins CS, Lanciotti RS, Busch MP,. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion 2008; 48: 1355-62.
40. Mohammed H, Linnen JM, Munoz-Jordan JL, Tomashek K, Foster G, Broulik AS, Petersen L, Stramer SL,. Dengue virus in blood donations, Puerto Rico, 2005. Transfusion 2008; 48: 1348-54.
41. Petersen LR, Tomashek KM, Biggerstaff BJ,. Estimated prevalence of dengue viremia in Puerto Rican blood donations, 1995 through 2010. Transfusion 2012; 52: 1647-51.
42. Mohammed H, Tomashek KM, Stramer SL, Hunsperger E,. Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006. Transfusion 2012; 52: 1652-6.
43. Stramer SL, Linnen JM, Carrick JM, Foster GA, Krysztof DE, Zou S, Dodd RY, Tirado-Marrero LM, Hunsperger E, Santiago GA, Muñoz-Jordan JL, Tomashek KM,. Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 2012; 52: 1657-66.
44. Dias LL, Amarilla AA, Poloni TR, Covas DT, Aquino VH, Moraes Figueiredo LT,. Detection of dengue virus in sera of Brazilian blood donors. Transfusion 2012; 52: 1667-71.
45. Teo D, Ng LC, Lam S,. Is dengue a threat to the blood supply? Transfus Med 2009; 19: 66-77.
46. Munoz-Jordan JL, Collins CS, Vergne E, Santiago GA, Petersen L, Sun W, Linnen JM,. Highly sensitive detection of dengue virus nucleic acid in samples from clinically ill patients. J Clin Microbiol 2009; 47: 927-31.
47. Stramer SL, Gregory A, Boucher C, Miller D, Dickson SS, Lenes BA, Carrick JM, Linnen J, Lanteri MC, Bentsen C,. Comparing the yield of dengue viremic blood donations using NS1 antigen (Ag) and NAT [abstract]. Transfusion 2011; 51 Suppl 3: 4A.
48. Busch MP, Glynn SA,. Use of blood-donor and transfusion-recipient biospecimen repositories to address emerging blood-safety concerns and advance infectious disease research: the National Heart, Lung, and Blood Institute Biologic Specimen Repository. J Infect Dis 2009; 199: 1564-6.
49. Delwart EL,. Viral metagenomics. Rev Med Virol 2007; 17: 115-31.
50. Katz LM,. How can the blood transfusion medicine community contribute to public health in tough economic times? J Infect Dis 2012; 205: 867-9.
51. Glynn SA, Busch MP, Dodd RY, Katz LM, Stramer SL, Klein HG, Simmons G, Kleinman SH, Shurin SB,; NHLBI Emerging Infectious Disease (EID) Task Force. Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century. Transfusion 2012; doi: 10.1111/j.1537-2995.2012.03742.x.
52. Gallagher LM, Ganz PR, Yang H, Kessler DA, O'Brien SF, Custer BS, Busch MP, Dodd RY, Stramer SL, Walderhaug MO, Forshee RA, Williams AE, Epstein JS, Anderson SA,. Data and data needs to advance risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop. Transfusion 2012; doi: 10.1111/j.1537-2995.2012.03808.x.
53. Custer BS,. Good evidence begets good policy: or so it should be. Transfusion 2012; 52: 463-5.